Clinical trial
Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central…
NCT00346424 · ARCA Biopharma, Inc., Industry · Completed
Key facts
| NCT number | NCT00346424 |
|---|---|
| Title | Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters |
| Official title | Phase 3, Multicenter, Multi-National, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alfimeprase in Subjects With Occluded Central Venous Access Devices |
| Lead sponsor | ARCA Biopharma, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thrombosis, Venous Thrombosis |
| Intervention type | Drug |
| Interventions | Alfimeprase |
| Enrollment | 300 |
| Start date | Sep 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jun 30, 2006 |
| Last update posted | Aug 14, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: